…e shown for (C) CRC molecular subtype (CIN, GS and MSI) and (D) CRC disease stage. CALCRL gene expression z-scores are displayed fo…
mCRC
This disease is selected. Its supporting articles are shown below.
Articles mentioning mCRC
12 articles · page 1 of 1…Background Colorectal cancer (CRC) is the third most prevalent cancer globally. 1 Approximat…
…nts A cross-sectional questionnaire survey was conducted on 164 mCRC adult patients.Outcome measures Using the five-level EuroQol-3-…
…mab as first-line and second-line treatment in BRAFV600E-Mutant mCRC from a single center.Methods We retrospectively reviewed the me…
…Background and Importance Colorectal cancer is the third most diagnosed cancer and the second leading cause…
…rated limited effectiveness in a heavily pre-treated real-world mCRC population, with poorer outcomes observed in patients with KRAS…
…I; and the American Lung Association and Lung Cancer Europe for NSCLC. Selection of patient-advocacy organisations was guided by thre…
…hods Observational, retrospective study including patients with mCRC treated with Bev-TAS between 19/01/2023-25/09/2025.Data collect…
…PI plus bevacizumab versus FTD-TPI monotherapy in patients with mCRC.Material and Methods Retrospective and observational study of p…
…ih, et al. Trifluridine-tipiracil and bevacizumab in refractory metastatic colorectal cancer. NEJM. 2023;388:1657–67.Kim, Lee, Yoo, et al. BTN1A1 is a novel…
…RAS-VAX with nivolumab and ipilimumab in patients with MMRp/MSS mCRC refractory to fluoropyrimidines, irinotecan, and oxaliplatin. P…
…obart with trifluridine/tipiracil and bevacizumab in refractory mCRC. This abstract reports Phase 1b safety run-in results focusing …